Prognostic models based on postoperative circulating tumor cells can predict poor tumor recurrence-free survival in patients with stage II-III colorectal cancer

Dong Wang(Sichuan University), Zhongtao Zhang(Capital Medical University), Hongwei Yao(Capital Medical University), Jin Wang(Stony Brook University), Jinghui Zhang(Capital Medical University), Yingchi Yang(Capital Medical University), Guocong Wu(Capital Medical University), Tiankuo Kou(Beijing Friendship Hospital), Xiaomu Zhao(Beijing Friendship Hospital), Lan Jin(Capital Medical University)
Journal of Cancer
January 1, 2019
10.7150/jca.30512
Cited by 40

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trial
|The Lancet Oncology|2021|184
A Multicenter Study on Etiology of Acute Pancreatitis in Beijing During 5 Years
|Pancreas|2014|147
Microalgae‐Based Hydrogel for Inflammatory Bowel Disease and Its Associated Anxiety and Depression
|Advanced Materials|2024|115
Electroacupuncture vs Sham Electroacupuncture in the Treatment of Postoperative Ileus After Laparoscopic Surgery for Colorectal Cancer
|JAMA Surgery|2022|111